Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Helm

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
British Journal of Cancer|February 1, 1992
Prognostic impact of chromosome aberrations in ovarian cancerT Pejovic, A Himmelmann, S Heim, et al.
Journal of Hematotherapy|October 1, 1995
G-CSF-stimulated PMN in immunotherapy of breast cancer with a bispecific antibody to Fc gamma RI and to HER-2/neu (MDX-210)R Repp, T Valerius, G Wieland, et al.
Cytometry. Part B, Clinical Cytometry|April 30, 2003
Immunophenotyping is an independent factor for risk stratification in AMLR Repp, U Schaekel, G Helm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: results of a prospective comparative analysis of the German Low-Grade Lymphoma Study GroupW Hiddemann, M Unterhalt, R Herrmann, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
British Journal of Cancer|February 1, 1992
Prognostic impact of chromosome aberrations in ovarian cancerT Pejovic, A Himmelmann, S Heim, et al.
Journal of Hematotherapy|October 1, 1995
G-CSF-stimulated PMN in immunotherapy of breast cancer with a bispecific antibody to Fc gamma RI and to HER-2/neu (MDX-210)R Repp, T Valerius, G Wieland, et al.
Cytometry. Part B, Clinical Cytometry|April 30, 2003
Immunophenotyping is an independent factor for risk stratification in AMLR Repp, U Schaekel, G Helm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: results of a prospective comparative analysis of the German Low-Grade Lymphoma Study GroupW Hiddemann, M Unterhalt, R Herrmann, et al.
Pageof 5